Keyphrases
Armamentarium
25%
Axitinib
25%
Bevacizumab
25%
Cabozantinib
25%
Cancer Genomics
25%
Cancer Mortality
25%
Clear Cell Renal Cell Carcinoma (ccRCC)
50%
Clinical Practice Guidelines
25%
Conventional Chemotherapy
25%
Epigenetics
25%
Everolimus
25%
Genomic Studies
25%
Histological Subtypes
25%
Kidney
25%
Lenvatinib
25%
Localized Renal Cell Carcinoma
25%
Mammalian Target of Rapamycin (mTOR)
25%
Metastatic Renal Cell Carcinoma (mRCC)
75%
Molecular Subtypes
25%
Nivolumab
25%
Pazopanib
25%
Prognostic Relevance
25%
Regulatory Genes
25%
Renal Cell Carcinoma
100%
Renal Epithelium
25%
Sorafenib
25%
Sunitinib
25%
Targeted Agents
25%
Temsirolimus
25%
Therapeutic Relevance
25%
Tumor Heterogeneity
25%
Vascular Endothelial Growth Factor
25%
Vascular Endothelial Growth Factor Receptor (VEGFR)
50%
VHL Gene
25%
Medicine and Dentistry
Axitinib
16%
Bevacizumab
16%
Cabozantinib
16%
Cancer
16%
Clear Cell
16%
Clear Cell Renal Cell Carcinoma
100%
Clinical Guideline
16%
Diseases
16%
Everolimus
16%
Immunotherapy
16%
Kidney Metastasis
50%
Lenvatinib
16%
Malignant Neoplasm
50%
Mammalian Target of Rapamycin Complex 1
16%
Nivolumab
16%
Pazopanib
16%
Receptor
16%
Regulator Gene
16%
Somatics
16%
Sorafenib
16%
Sunitinib
16%
Temsirolimus
16%
Tumour Heterogeneity
16%
Vasculotropin
16%